Pfizer’s trial data was clear all along: More harm than good, researcher finds
| (NaturalNews) The pivotal Pfizer COVID-19 vaccine trial never proved benefits outweighed risks, according to a new analysis by researcher Yaakov Ophir. The w... |
Related Markets
All MarketsMarket data may be delayed. Not financial advice.
💡 AI analysis provides alternative perspectives on current events